There is currently no real consensus on the optimal management of acute sprains of the proximal interphalangeal joint of the long fingers. The aim of this study is to assess the beneficial effect of an injection of corticosteroids for the treatment of this type of sprain (one single sub-cutaneous injection, in the acute phase). This treatment, if effective, might become the treatment of choice for these types of injuries, instead of a prolonged immobilization or a careful early mobilization.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
60
Single subcutaneous injection of Diprophos, in the acute phase.
CHU Brugmann
Brussels, Belgium
Clinique du Parc Leopold
Brussels, Belgium
Flexion/extension deficit
Evaluation of the maximal amplitude of the articulation, as measured by a goniometer.
Time frame: Baseline (day of kenacort injection)
Flexion/extension deficit
Evaluation of the maximal amplitude of the articulation, as measured by a goniometer.
Time frame: 7 days after injection
Flexion/extension deficit
Evaluation of the maximal amplitude of the articulation, as measured by a goniometer.
Time frame: 30 days after injection
Laxity in hyperextension
Evaluation of the maximal amplitude of the articulation, as measured by a goniometer.
Time frame: Baseline (day of kenacort injection)
Laxity in hyperextension
Evaluation of the maximal amplitude of the articulation, as measured by a goniometer.
Time frame: 7 days after injection
Laxity in hyperextension
Evaluation of the maximal amplitude of the articulation, as measured by a goniometer
Time frame: 30 days after injection
Diameter of the articulation
Oedema evaluation. Collateral comparison with the same finger of the other hand: result expressed as a ratio
Time frame: Baseline (day of kenacort injection)
Diameter of the articulation
Oedema evaluation. Collateral comparison with the same finger of the other hand: result expressed as a ratio
Time frame: 7 days after injection
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Diameter of the articulation
Oedema evaluation. Collateral comparison with the same finger of the other hand: result expressed as a ratio
Time frame: 30 days after injection
Prehension force
Assessed by a dynamometer (Jamar hydraulic gauge). Result expressed as a ratio with the prehension force of the non-injured hand.
Time frame: Baseline (day of kenacort injection)
Prehension force
Assessed by a dynamometer (Jamar hydraulic gauge). Result expressed as a ratio with the prehension force of the non-injured hand.
Time frame: 7 days after injection
Prehension force
Assessed by a dynamometer (Jamar hydraulic gauge). Result expressed as a ratio with the prehension force of the non-injured hand.
Time frame: 30 days after injection
EVA scale
Pain assessment at the level of the volar plate
Time frame: 7 days after injection
EVA scale
Pain assessment at the level of the volar plate
Time frame: 30 days after injection
Mini-DASH
Assessment of the return to daily life activities or sport activities. Questionnaire of the Disabilities of the Arm, Shoulder and Hand.
Time frame: 7 days after injection
Mini-DASH
Assessment of the return to daily life activities or sport activities. Questionnaire of the Disabilities of the Arm, Shoulder and Hand.
Time frame: 30 days after injection
Mitchigan Hand Questionnaire
Auto-evaluation of the patient regarding the functionality of his/her articulation
Time frame: 7 days after injection
Mitchigan Hand Questionnaire
Auto-evaluation of the patient regarding the functionality of his/her articulation
Time frame: 30 days after injection